Clinical Trial · NCT04030338

Prostate-Specific Membrane Antigen (PSMA) PET Scans in People with Prostate Cancer

Overview

The purpose of this study is to determine if Prostate-Specific Membrane Antigen (PSMA) positron emission tomography (PET) scans used in this study accurate and better at imaging participants' prostate cancer than the usual methods.

Sponsor

Progenics Pharmaceuticals

Phase

N/A

ClinicalTrials.gov

NCT04030338